These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24332231)

  • 1. Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
    Mortimer D; Gelfius CD; Potts MA
    PM R; 2013 Dec; 5(12):1077-80. PubMed ID: 24332231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
    Perry D; Birthi P; Salles S; McDowell S
    PM R; 2012 May; 4(5):383-4. PubMed ID: 22613365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical results of using Nakom in diseases of the nervous system].
    Evtushenko SK; Sadekov IA; Samsonenko RA; Mogilevskaia GS; Prokhorova LM; Ostropolets SS; Osadchiĭ VG; Va'skovskaia ME
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):35-7. PubMed ID: 2686319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor benefit from levodopa in spastic quadriplegic cerebral palsy.
    Brunstrom JE; Bastian AJ; Wong M; Mink JW
    Ann Neurol; 2000 May; 47(5):662-5. PubMed ID: 10805341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
    Ahlskog JE
    Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
    Metman LV; Blanchet PJ; de Jong D; Mouradian MM; Chase TN
    Mov Disord; 1996 May; 11(3):257-60. PubMed ID: 8723141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is Not in the Name? Dopa-Responsive Dystonia May Respond to More Than L-Dopa.
    Friedman JR
    Pediatr Neurol; 2016 Jun; 59():76-80. PubMed ID: 27080360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief case report: dopa-responsive dystonia.
    Heidenreich WF
    J Insur Med; 2013; 43(4):244-6. PubMed ID: 24069785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

  • 11. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease patients cannot get their dopamine replacement: the 8-Sinemet limit.
    Okun MS
    Mov Disord; 2012 Mar; 27(3):461-2. PubMed ID: 22162080
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical treatment of later-stage motor problems of Parkinson disease.
    Ahlskog JE
    Mayo Clin Proc; 1999 Dec; 74(12):1239-54. PubMed ID: 10593354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy: problems and practices.
    Muenter MD
    Clin Neuropharmacol; 1986; 9 Suppl 1():S23-36. PubMed ID: 3708606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prolactin and thyrotropic hormone content of the blood plasma in neostriatal dysfunction].
    Iakimovskiĭ AF; Arutiunian NA
    Fiziol Zh Im I M Sechenova; 1995 Dec; 81(12):108-14. PubMed ID: 8754036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The place of L-dopa/carbidopa in persistent vegetative state.
    Ugoya SO; Akinyemi RO
    Clin Neuropharmacol; 2010; 33(6):279-84. PubMed ID: 21060281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury.
    Wilkinson R; Meythaler JM; Guin-Renfroe S
    Brain Inj; 1999 Dec; 13(12):1025-31. PubMed ID: 10628507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa does not improve function in individuals with dystonic cerebral palsy.
    Pozin I; Bdolah-Abram T; Ben-Pazi H
    J Child Neurol; 2014 Apr; 29(4):534-7. PubMed ID: 23349519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial treatment of Parkinson's disease].
    Kulisevsky J; López-Villegas D
    Rev Neurol; 1997 Aug; 25 Suppl 2():S163-9. PubMed ID: 9280684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.